Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTErAMG 330
Laszlo, George S., Beddoe, Mary E., Godwin, Colin D., Bates, Olivia M., Gudgeon, Chelsea J., Harrington, Kimberly H., Walter, Roland B.Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2018.202069
Date:
August, 2018
File:
PDF, 1.60 MB
english, 2018